FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 60 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $127,000 | +15.5% | 38,420 | +5.4% | 0.00% | – |
| Q3 2019 | $110,000 | +5400.0% | 36,453 | +2828.0% | 0.00% | – |
| Q2 2019 | $2,000 | -90.0% | 1,245 | -78.7% | 0.00% | – |
| Q4 2018 | $20,000 | +33.3% | 5,837 | +110.4% | 0.00% | – |
| Q3 2018 | $15,000 | -80.5% | 2,774 | -82.0% | 0.00% | – |
| Q2 2018 | $77,000 | +600.0% | 15,445 | +618.0% | 0.00% | – |
| Q1 2018 | $11,000 | -63.3% | 2,151 | -61.2% | 0.00% | -100.0% |
| Q3 2017 | $30,000 | -50.0% | 5,541 | -57.2% | 0.00% | -66.7% |
| Q2 2017 | $60,000 | – | 12,934 | +12834.0% | 0.00% | – |
| Q1 2017 | $0 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,293,177 | $4,643,000 | 4.08% |
| GREAT POINT PARTNERS LLC | 4,047,561 | $14,531,000 | 1.84% |
| Sio Capital Management, LLC | 1,151,510 | $4,134,000 | 1.51% |
| DAFNA Capital Management LLC | 808,000 | $2,901,000 | 1.44% |
| Diag Capital Management, LP | 146,432 | $960,000 | 1.10% |
| Perceptive Advisors | 4,661,824 | $15,850,000 | 0.60% |
| Eversept Partners, LP | 294,660 | $1,057,829 | 0.57% |
| Sofinnova Investments, Inc. | 832,293 | $2,987,000 | 0.37% |
| KNOTT DAVID M | 206,200 | $740,000 | 0.35% |
| Orbimed Advisors | 5,195,330 | $18,651,000 | 0.34% |